Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-31 5:17 pm Sale |
2023-08-31 | 13D | Pardes Biosciences, Inc. PRDS |
FS Development Holdings II LLC | 1,000 100.000% |
-16,812,146 (-99.99%) |
Filing History |
| 2023-07-17 07:55 am Unchanged |
2023-07-16 | 13D | Pardes Biosciences, Inc. PRDS |
FS Development Holdings II LLC | 16,813,146 27.240% |
0 (Unchanged) |
Filing History |
| 2023-04-21 4:28 pm Unchanged |
2023-04-20 | 13D | Pardes Biosciences, Inc. PRDS |
FS Development Holdings II LLC | 16,813,146 27.240% |
0 (Unchanged) |
Filing History |
| 2023-04-06 9:07 pm Purchase |
2023-04-05 | 13D | Pardes Biosciences, Inc. PRDS |
FS Development Holdings II LLC | 16,813,146 27.240% |
1,547,904 (+10.14%) |
Filing History |
| 2022-12-05 4:23 pm Purchase |
2022-12-01 | 13D | Pardes Biosciences, Inc. PRDS |
FS Development Holdings II LLC | 15,265,242 24.490% |
637,420 (+4.36%) |
Filing History |
| 2021-12-30 5:09 pm Purchase |
2021-12-23 | 13D | Pardes Biosciences, Inc. PRDS |
FS Development Holdings II LLC | 14,627,822 23.450% |
14,627,822 (New Position) |
Filing History |